MindMed Appoints University of North Carolina Psychiatrist and Pharmacologist Dr. Bryan Roth to Scientific Advisory… Sep 29, 2021
Mindset Pharma Announces Preclinical Results Demonstrating Extended Duration of Action in its Long-Acting Next… Aug 26, 2021
Mindset Pharma Broadens its IP Portfolio by Filing U.S. Provisional Patent Extending its DMT and 5-MeO-DMT Inspired… Aug 24, 2021
Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of Florida Aug 24, 2021
Cybin Strengthens IP Portfolio By Filing Of 16th Patent Application: Psychedelic Investors React Aug 20, 2021
Mindset Pharma Announces Preclinical Results Demonstrating Superior Efficacy, Safety and Shorter Duration of Action… Aug 10, 2021
MINDCURE Appoints Jerry White, Award-Winning Humanitarian Activist Who Shares in the 1997 Nobel Peace Prize, as Company… Aug 4, 2021
PsyBio Therapeutics Augments Intellectual Property Portfolio with Filing of Next Novel Psychedelic Compositions and… Jul 13, 2021
